196 related articles for article (PubMed ID: 35849394)
1. Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan.
Chiang CJ; Jhuang JR; Yang YW; Zhuang BZ; You SL; Lee WC; Chen CJ
JAMA Netw Open; 2022 Jul; 5(7):e2222367. PubMed ID: 35849394
[TBL] [Abstract][Full Text] [Related]
2. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan.
Liao SH; Chen CL; Hsu CY; Chien KL; Kao JH; Chen PJ; Chen TH; Chen CH
J Hepatol; 2021 Jul; 75(1):132-141. PubMed ID: 33689789
[TBL] [Abstract][Full Text] [Related]
4. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.
Wu CY; Chen YJ; Ho HJ; Hsu YC; Kuo KN; Wu MS; Lin JT
JAMA; 2012 Nov; 308(18):1906-14. PubMed ID: 23162861
[TBL] [Abstract][Full Text] [Related]
5. Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
Yeh YC; Liu CJ; Kuo RN; Lai CL; Shau WY; Chen PJ; Lai MS
PLoS One; 2014; 9(7):e102051. PubMed ID: 25025231
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls.
Chang MH; Shau WY; Chen CJ; Wu TC; Kong MS; Liang DC; Hsu HM; Chen HL; Hsu HY; Chen DS;
JAMA; 2000 Dec; 284(23):3040-2. PubMed ID: 11122592
[TBL] [Abstract][Full Text] [Related]
7. National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in Taiwan: a preliminary report.
Chang CH; Lin JW; Wu LC; Liu CH; Lai MS
Med Care; 2013 Oct; 51(10):908-13. PubMed ID: 23969591
[TBL] [Abstract][Full Text] [Related]
8. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
[TBL] [Abstract][Full Text] [Related]
9. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
[TBL] [Abstract][Full Text] [Related]
10. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
Chang MH; You SL; Chen CJ; Liu CJ; Lai MW; Wu TC; Wu SF; Lee CM; Yang SS; Chu HC; Wang TE; Chen BW; Chuang WL; Soon MS; Lin CY; Chiou ST; Kuo HS; Chen DS;
Gastroenterology; 2016 Sep; 151(3):472-480.e1. PubMed ID: 27269245
[TBL] [Abstract][Full Text] [Related]
11. Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ
J Viral Hepat; 2023 Jun; 30(6):520-529. PubMed ID: 36843500
[TBL] [Abstract][Full Text] [Related]
12. Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan.
Chang CH; Lin JW; Tu YK
J Clin Epidemiol; 2015 Apr; 68(4):405-11. PubMed ID: 25660961
[TBL] [Abstract][Full Text] [Related]
13. Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.
Choi J; Kim HJ; Lee J; Cho S; Ko MJ; Lim YS
JAMA Oncol; 2019 Jan; 5(1):30-36. PubMed ID: 30267080
[TBL] [Abstract][Full Text] [Related]
14. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
[TBL] [Abstract][Full Text] [Related]
15. Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.
Hsu YC; Yip TC; Ho HJ; Wong VW; Huang YT; El-Serag HB; Lee TY; Wu MS; Lin JT; Wong GL; Wu CY
J Hepatol; 2018 Aug; 69(2):278-285. PubMed ID: 29551708
[TBL] [Abstract][Full Text] [Related]
16. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
17. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
[TBL] [Abstract][Full Text] [Related]
18. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.
Chien YC; Jan CF; Chiang CJ; Kuo HS; You SL; Chen CJ
Hepatology; 2014 Jul; 60(1):125-32. PubMed ID: 24497203
[TBL] [Abstract][Full Text] [Related]
19. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.
Moon AM; Singal AG; Tapper EB
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2650-2666. PubMed ID: 31401364
[TBL] [Abstract][Full Text] [Related]
20. The impact of national viral hepatitis therapy program and hepatitis B vaccination program on mortality from acute and chronic viral hepatitis in Taiwan.
Su SY
Hepatol Int; 2019 Mar; 13(2):157-164. PubMed ID: 30706354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
